Sinusoidal Obstruction Syndrome/Hepatic Veno-Occlusive Disease

VT Ho, NA Kernan, E Carreras… - Vascular Disorders of the …, 2022 - Springer
Sinusoidal obstruction syndrome (SOS), or hepatic veno-occlusive disease (VOD), is a
potentially life-threatening complication that occurs primarily after myeloablative …

Modulación farmacológica de la disfunción endotelial en la uremia

M Vera Rivera - 2020 - diposit.ub.edu
[spa] La enfermedad cardiovascular (CV) es la principal causa de muerte de los pacientes
con enfermedad renal crónica terminal (ERCT). Es especialmente llamativa la diferencia …

Heptapeptide-based modification leading to enhancing the action of MTCA on activated platelets, P-selectin, GPIIb/IIIa

Z Li, F Huang, J Wu, L Gui, X Zhang… - Future Medicinal …, 2018 - Taylor & Francis
Aim: The modification of platelet inhibitor to enhance its targeting capacity toward platelets is
of clinical importance. Thus,(1R, 3S)-1-methyl-1, 2, 3, 4-tetrahydro-β-carboline-3-carboxylic …

An analysis of responses to defibrotide in the pulmonary vascular bed of the cat

AD Kaye, BD Skonieczny, AJ Kaye… - American Journal of …, 2016 - journals.lww.com
Defibrotide is a polydisperse mixture of single-stranded oligonucleotides with many
pharmacologic properties and multiple actions on the vascular endothelium. Responses to …

Enfermedad Veno-oclusiva Hepática/Síndrome de Obstrucción Sinusoidal: actualización de los aspectos fisiopatológicos, criterios diagnósticos y opciones …

RN Nasser, MC Vega, NC Álvarez - Oncología (Ecuador), 2017 - roe.solca.med.ec
La enfermedad veno-oclusiva hepática o síndrome de obstrucción sinusoidal se caracteriza
clínicamente por presentar hepatomegalia dolorosa, ictericia, ascitis, edema, aumento de …

[PDF][PDF] Development of an automated micromixer for the controlled formulation of multi-component polyplexes

D Loy - 2021 - edoc.ub.uni-muenchen.de
Development of an automated micromixer for the controlled formulation of multi-component
polyplexes Page 1 Dissertation zur Erlangung des Doktorgrades der Fakultät für Chemie …

[PDF][PDF] An Update on Antiphospholipid Syndrome Including C APS & Obstetric Management-A Case Report having Prior 7 Pregnancy Losses Presenting with Stroke …

KK Kaur, G Allahbadia, M Singh - 2021 - researchgate.net
Antiphospholipid syndrome (APS) represents an autoimmune thrombo inflammatory
condition that can present with different clinical phenotypes. Here we present a report of a …

Literature review in field of drugs influencing blood clotting

K Kolotsios - 2015 - dspace.cuni.cz
Charles University in Prague Faculty of Pharmacy in Hradec Králové Department of
Pharmaceutical Chemistry and Drug Control Student: Konstantinos Kolotsios Consultant …

Does defibrotide induce a delay to polymorphonuclear neutrophil engraftment after hematopoietic stem cell transplantation? Observation in a pediatric population

N Maximova, A Pizzol, N Giurici, M Granzotto - Advances in Therapy, 2015 - Springer
Introduction In recent years, defibrotide (DFT) has emerged as a promising therapy for veno-
occlusive disease (VOD). The aim of this study was to investigate whether DFT prophylaxis …

Defibrotide for the prevention and treatment of cytokine release syndrome and neurotoxicity associated with immunodepletion

S McMahon, Y Oki - US Patent App. 18/080,954, 2023 - Google Patents
The present disclosure provides method of preventing, lessening the effects, or treating
cytokine release syndrome (CRS) or related disorders, and/or neurotoxicity associated with …